Loading...

MGX METAGENOMI THERAPEUTICS INC Management Changes 8-K Filing

MTGN

MGX

METAGENOMI THERAPEUTICS INC

(MGX)

2025 8-K

Financial Results Update

Name Change Announcement

Financial Update

License Agreement Signed

Product Expansion

Financial Statements

Financial Results

Board Appointment

Data Presentation

Financial Results

Gene Therapy Update

External Links:

On June 10, 2025, Metagenomi, Inc. held its annual meeting, where shareholders elected Willard H. Dere, M.D. to the board and ratified PricewaterhouseCoopers as their auditor for 2025. A total of 18,765,221 shares voted, establishing a quorum.

AI Assistant

METAGENOMI THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.